Clinical trial · Interventional
Effects of Acupuncture on Aromatase Inhibitor-Induced Joint Pain
NCT02548637CI-TRIAL-00028636completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Researchers at the John Wayne Cancer Institute (JWCI) at Providence Saint John's Health Center (PSJHC) are trying to examine whether acupuncture reduces joint pain in patients being treated with aromatase inhibitor (AI) therapy for breast cancer and whether the reduction in pain happens by lowering inflammation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture Therapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Acupuncture Therapy
- description
- Based on the Traditional Chinese Medicine theory, investigators will use the systemic treatment methods (full body treatment with the joint specifications). Every patient will receive the standard protocols of these points uniformly regardless of their symptoms. The only variable will be the location of placement of the four electrodes (two positive charges and two negative charges) to the needle points at the most painful joints bilaterally. Needles will be in place a total of 45 minutes per session. The Thermal Design Power (TDP) infrared heat lamp will be applied concurrently to the most painful joint(s) for the entire 45 minutes. Acupuncture will be administered twice a week for 6 weeks, then once a week for an additional 4 weeks.
- interventionNames
- Procedure: Acupuncture Therapy
Primary outcomes (1)
- measure
- Joint Pain tabulated from Joint Pain Assessment Questionnaire
- timeFrame
- 3 years
- description
- Investigators will serially measure joint pain symptoms using questionnaires administered at pre-determined time points. A summary of pain scores will be tabulated for all visits.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female * Must be on aromatase inhibitor therapy continuously for breast cancer treatment for at least the preceding two months * Must have experienced increased or new onset joint pain daily to a degree equal to or greater than 4 on a pain scale of 0-10 after starting aromatase inhibitor therapy * Able to read and write English * Able to give written informed consent to participate in the study Exclusion Criteria: * Have a known autoimmune disease or acute infection * Have had acupuncture treatment within 6 months of study enrollment * Known needle phobia * Known metal allergies * Have an implantable device, such as pacemaker, defibrillator or other device contraindicated with electrical stimulation * Use of nonsteroidal antiinflammatory drugs (NSAIDs) or narcotics within 7 days of study enrollment and during study period (15 weeks) * Receipt of prior chemotherapy, immunotherapy or radiation therapy within 90 days * On anticoagulant therapy * Receiving physical or occupational therapy concurrently * Taking herbs or herbal teas within 7 days of study enrollment and during study period (15 weeks) * Have an immune-compromising medical condition or currently receiving immune-modulating therapies (including corticosteroids) * Enrolled in any other active cancer treatment protocols * Bone fracture or surgery of an affected extremity within 6 months
References
Publications (0)
Data not yet available
No reference posted for this study.